Prolonged feeding of difructose anhydride III increases strength and mineral concentrations of the femur in ovariectomized rats.
This study demonstrates that feeding difructose anhydride III (DFAIII) improves bone strength and femoral mineral concentrations in a rat model of oestrogen deficiency. We showed the relationship between Ca, Mg and P absorption and bone characteristics in rats. Two groups of female Sprague-Dawley rats (6 weeks old) underwent bilateral ovariectomy (ovariectomized rats, OVX rats) or bilateral laparotomy (sham rats). At 10 weeks old, OVX and sham rats were divided into three subgroups and fed a control, 1.5 % DFAIII or 3 % DFAIII diet for 8 weeks, respectively. Ca but not Mg absorption rates were lowered by ovariectomy; however, ingestion of the 1.5 % and 3 % DFAIII diets similarly restored the reduced Ca absorption in OVX rats at 4 and 8 weeks after feeding of the test diets. DFAIII increased Mg absorption dose-dependently in sham and OVX rats. The bone strength, femoral Ca and Mg concentrations, and distal bone mineral density in the 3 % DFAIII group were higher than those in the control group in OVX rats. The absorption rates of Ca and Mg were significantly correlated with femoral Ca and Mg concentrations and strength, which suggests that increasing both Ca and Mg absorption improves bone characteristics in OVX rats. There were no differences in any of the variables in the femur between the 1.5 % and 3 % DFAIII groups in OVX rats. In conclusion, feeding of a low dose of DFAIII increased intestinal Ca and Mg absorption, and the promotive effect of DFAIII persisted for over 8 weeks. This effect was associated with prevention of ovariectomy-induced osteopenia.
Mitamura
Rieko
R
Division of Applied Bioscience, Graduate School of Agriculture, Hokkaido University, Kita-9, Nishi-9, Sapporo 060-8589, Japan.
Hara
Hiroshi
H
D000042:Absorption; D000596:Amino Acids / Q000652:urine; D000818:Animals; D015415:Biomarkers / Q000652:urine; D001835:Body Weight / Q000502:physiology; D015519:Bone Density / Q000502:physiology; D002118:Calcium / Q000493:pharmacokinetics*; D019587:Dietary Supplements; D004187:Disaccharides / Q000008:administration & dosage*; D004435:Eating / Q000502:physiology; D005260:Female; D005269:Femur / Q000378:metabolism / Q000502:physiology*; D006909:Hydroxyproline / Q000032:analysis; D008274:Magnesium / Q000493:pharmacokinetics; D010052:Ovariectomy; D010758:Phosphorus / Q000493:pharmacokinetics; D051381:Rats
D000596:Amino Acids; D015415:Biomarkers; D004187:Disaccharides; D010758:Phosphorus; C087758:difructose anhydride III; C036020:deoxypyridinoline; D008274:Magnesium; D006909:Hydroxyproline; D002118:Calcium